Literature DB >> 23261405

The neurobiology of depression and antidepressant action.

Paul Willner1, Jørgen Scheel-Krüger, Catherine Belzung.   

Abstract

We present a comprehensive overview of the neurobiology of unipolar major depression and antidepressant drug action, integrating data from affective neuroscience, neuro- and psychopharmacology, neuroendocrinology, neuroanatomy, and molecular biology. We suggest that the problem of depression comprises three sub-problems: first episodes in people with low vulnerability ('simple' depressions), which are strongly stress-dependent; an increase in vulnerability and autonomy from stress that develops over episodes of depression (kindling); and factors that confer vulnerability to a first episode (a depressive diathesis). We describe key processes in the onset of a 'simple' depression and show that kindling and depressive diatheses reproduce many of the neurobiological features of depression. We also review the neurobiological mechanisms of antidepressant drug action, and show that resistance to antidepressant treatment is associated with genetic and other factors that are largely similar to those implicated in vulnerability to depression. We discuss the implications of these conclusions for the understanding and treatment of depression, and make some strategic recommendations for future research.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Affective neuroscience; Amygdala; Anterior cingulate cortex; Antidepressant drugs; Caudate nucleus; Habenula; Hippocampus; Nucleus accumbens; Stress; Treatment resistance; Unipolar major depression; Ventromedial prefrontal cortex

Mesh:

Substances:

Year:  2012        PMID: 23261405     DOI: 10.1016/j.neubiorev.2012.12.007

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  107 in total

Review 1.  Differential Susceptibility of the Developing Brain to Contextual Adversity and Stress.

Authors:  W Thomas Boyce
Journal:  Neuropsychopharmacology       Date:  2015-09-22       Impact factor: 7.853

2.  A machine learning framework involving EEG-based functional connectivity to diagnose major depressive disorder (MDD).

Authors:  Wajid Mumtaz; Syed Saad Azhar Ali; Mohd Azhar Mohd Yasin; Aamir Saeed Malik
Journal:  Med Biol Eng Comput       Date:  2017-07-13       Impact factor: 2.602

3.  Enduring good memories of infant trauma: rescue of adult neurobehavioral deficits via amygdala serotonin and corticosterone interaction.

Authors:  Millie Rincón-Cortés; Gordon A Barr; Anne Marie Mouly; Kiseko Shionoya; Bestina S Nuñez; Regina M Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

4.  Antidepressant-Like Effect of Bauhinia blakeana Dunn in a Neuroinflammation Model in Mice.

Authors:  Maribel Herrera-Ruiz; Mayra A Santillán-Urquiza; Ofelia Romero-Cerecero; Alejandro Zamilpa; Enrique Jiménez-Ferrer; Jaime Tortoriello
Journal:  Med Princ Pract       Date:  2019-08-30       Impact factor: 1.927

5.  Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters.

Authors:  Sawsan Aboul-Fotouh
Journal:  Psychopharmacology (Berl)       Date:  2014-10-15       Impact factor: 4.530

6.  Antidepressant Effects of Ketamine Are Not Related to ¹⁸F-FDG Metabolism or Tyrosine Hydroxylase Immunoreactivity in the Ventral Tegmental Area of Wistar Rats.

Authors:  Pedro Porto Alegre Baptista; Lisiani Saur; Pamela Bambrilla Bagatini; Samuel Greggio; Gianina Teribele Venturin; Sabrina Pereira Vaz; Kelly Dos Reis Ferreira; Juliana Silva Junqueira; Diogo Rizzato Lara; Jaderson Costa DaCosta; Cristina Maria Moriguchi Jeckel; Régis Gemerasca Mestriner; Léder Leal Xavier
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

7.  Modulation of Monoaminergic Systems by Antidepressants in the Frontal Cortex of Rats After Chronic Mild Stress Exposure.

Authors:  David Martín-Hernández; Marta P Pereira; Hiram Tendilla-Beltrán; José L M Madrigal; Borja García-Bueno; Juan C Leza; Javier R Caso
Journal:  Mol Neurobiol       Date:  2019-05-03       Impact factor: 5.590

Review 8.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

9.  Astrocyte Intracellular Ca2+and TrkB Signaling in the Hippocampus Could Be Involved in the Beneficial Behavioral Effects of Antidepressant Treatment.

Authors:  Frederico R Ferreira; Alexander Cupido; Bogdan Catalin; Wilson A Silva; Frank Kirchhoff; Elaine A Del-Bel; Francisco S Guimarães
Journal:  Neurotox Res       Date:  2021-02-22       Impact factor: 3.911

Review 10.  Treatment-resistant depression: are animal models of depression fit for purpose?

Authors:  Paul Willner; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.